Hologic, a global women’s health medical technology company, has completed its acquisition by funds managed by Blackstone and TPG in a transaction valued at up to $79 per share, officially transitioning the company to private ownership. This deal added up to about $18.3 billion.
The deal, first announced in October 2025 and approved by shareholders in February 2026, provides stockholders with $76 per share in cash plus a non-tradable contingent value right that could add up to $3 per share based on future revenue milestones tied to Hologic’s Breast Health business in fiscal years 2026 and 2027.
As part of the transaction, Hologic has also named José (Joe) E. Almeida as Chief Executive Officer, effective immediately. Almeida previously served as Chairman, President, and CEO of Baxter International from 2016 to early 2025 and earlier led Covidien prior to its acquisition by Medtronic.
The transaction includes minority investments from a subsidiary of the Abu Dhabi Investment Authority and an affiliate of GIC, reinforcing institutional backing for the company’s next phase of growth.
Following the completion of the acquisition, Hologic’s common stock has ceased trading and has been delisted from the Nasdaq Stock Market.
Almeida succeeds Stephen MacMillan, who retired after more than 12 years leading the company. The new leadership is expected to focus on accelerating innovation and expanding Hologic’s mission of improving women’s health outcomes globally, supported by increased financial resources and strategic backing from its new private owners.
KEY QUOTES:
“Hologic is an incredible company with a storied history of innovation and an unparalleled reputation as a leader in women’s health. I am thrilled to be joining at such a pivotal moment. With the backing of Blackstone and TPG, we are poised to take the organization to new heights, with a renewed sense of purpose and greater resources to invest in innovation and initiatives that will advance the mission of enabling healthier lives around the world.”
José (Joe) E. Almeida, Chief Executive Officer, Hologic
“Hologic has established itself as a global leader in advancing women’s health, with a proven track record of delivering life-changing medical technologies. We are thrilled to partner with Joe Almeida — an exceptional medical technology leader — alongside Hologic’s talented team and TPG to drive the company’s next phase of growth and innovation.”
Ram Jagannath, Senior Managing Director and Global Head of Healthcare, Blackstone
“Hologic’s mission is to advance detection and care to improve health outcomes for women worldwide. Investing behind healthcare innovation has been a core thematic focus for TPG over decades, and we have long admired Hologic as an industry leader. Under Joe’s experienced and proven leadership, we are proud to partner with Hologic and Blackstone to support clinical excellence and deliver meaningful impact for patients.”
Alex Albert, Partner and Co-Head of Healthcare, TPG Capital
